• Whiteside T.L.

The tumor microenvironment and its role in promoting tumor growth.

Oncogene. 2008; 27: 5904-5912

• Duan Q.
• et al.

Turning cold into hot: firing up the tumor microenvironment.

Trends Cancer. 2020; 6: 605-618

• Nia H.T.
• et al.

Physical traits of cancer.

Science. 2020; 370: 6516

• Emon B.
• et al.

Biophysics of tumor microenvironment and cancer metastasis – a mini review.

Comput. Struct. Biotechnol. J. 2018; 16: 279-287

• Nazemi M.
• Rainero E.

Cross-talk between the tumor microenvironment, extracellular matrix, and cell metabolism in cancer.

Front. Oncol. 2020; 10: 1-7

• Kalluri R.

The biology and function of fibroblasts in cancer.

Nat. Rev. Cancer. 2016; 16: 582-598

• Monteiro M.V.
• et al.

Stratified 3D microtumors as organotypic testing platforms for screening pancreatic cancer therapies.

Small Methods. 2021; 52001207

• Wang C.
• et al.

Three-dimensional in vitro cancer models: a short review.

Biofabrication. 2014; 6022001

• Yang L.
• et al.

Tumor organoids: from inception to future in cancer research.

Cancer Lett. 2019; 454: 120-133

• Nunes A.S.
• et al.

3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.

Biotechnol. Bioeng. 2019; 116: 206-226

• Ferreira L.P.
• et al.

Design of spherically structured 3D in vitro tumor models -advances and prospects.

Acta Biomater. 2018; 75: 11-34

• Radhakrishnan J.
• et al.

Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips.

Drug Discov. Today. 2020; 25: 879-890

• Ferreira L.P.
• et al.

Bioinstructive microparticles for self-assembly of mesenchymal stem cell-3D tumor spheroids.

Biomaterials. 2018; 185: 155-173

• Fan H.
• et al.

Emerging organoid models: leaping forward in cancer research.

J. Hematol. Oncol. 2019; 12: 1-10

• Heinrich M.A.
• et al.

Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models.

Adv. Drug Deliv. Rev. 2021; 174: 265-293

• Li X.
• et al.

Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.

Nat. Med. 2014; 20: 769-777

• Kratochvil M.J.
• et al.

Engineered materials for organoid systems.

Nat. Rev. Mater. 2019; 4: 606-622

• Tuveson D.
• Clevers H.

Cancer modeling meets human organoid technology.

Science. 2019; 364: 952-955

• Skardal A.
• et al.

Organoid-on-a-chip and body-on-a- chip systems for drug screening and disease modeling.

Drug Discov. Today. 2016; 21: 1399-1411

• Tsai S.
• et al.

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.

BMC Cancer. 2018; 18: 1-13

• Monteiro M.V.
• et al.

Bioinspired biomaterials to develop cell-rich spherical microtissues for 3D in vitro tumor modeling.

in: Kundu S.C. Reis R.L. Biomaterials for 3D Tumor Modeling. Elsevier, 2020: 43-65

• Hinderer S.
• et al.

ECM and ECM-like materials — biomaterials for applications in regenerative medicine and cancer therapy.

Adv. Drug Deliv. Rev. 2016; 97: 260-269

• Fong E.L.S.
• et al.

Heralding a new paradigm in 3D tumor modeling.

Biomaterials. 2016; 108: 197-213

• Liaw C.Y.
• et al.

Engineering 3D hydrogels for personalized in vitro human tissue models.

Adv. Healthc. Mater. 2018; 71701165

• Caliari S.R.
• Burdick J.A.

A practical guide to hydrogels for cell culture.

Nat. Methods. 2016; 13: 405-414

• Liu H.Y.
• et al.

Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma.

Biomaterials. 2018; 160: 24-36

• Phelps A.S.
• et al.

Modelling cancer in microfluidic human organs-on-chips.

Nat. Rev. Cancer. 2019; 19: 65-81

• Langer E.M.
• et al.

Modeling tumor phenotypes in vitro with three-dimensional bioprinting.

Cell Rep. 2019; 26: 608-623

• Morgan F.L.C.
• et al.

Dynamic bioinks to advance bioprinting.

Adv. Healthc. Mater. 2020; 91901798

• Heinrich M.A.
• et al.

3D-bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics.

Adv. Mater. 2019; 311806590

• Ma X.
• et al.

Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.

Proc. Natl. Acad. Sci. U. S. A. 2016; 113: 2206-2211

• Chang S.-F.
• et al.

Tumor cell cycle arrest induced by shear stress: roles of integrins and Smad.

Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 3927-3932

• Azimi T.
• et al.

Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin.

Sci. Rep. 2020; 10: 1-10

• Yu F.
• Choudhury D.

Microfluidic bioprinting for organ-on-a-chip models.

Drug Discov. Today. 2019; 24: 1248-1258

• Hachey S.
• Hughes C.

Applications of tumor chip technology.

Lab Chip. 2018; 18: 2893-2912

• Thompson C.L.
• et al.

Mechanical stimulation: a crucial element of organ-on-chip models.

Front. Bioeng. Biotechnol. 2020; 8: 1426

• Kaarj K.
• Yoon J.-Y.

Methods of delivering mechanical stimuli to organ-on-a-chip.

Micromachines. 2019; 10: 700

• Ergir E.
• et al.

Small force, big impact: next generation organ-on-a-chip systems incorporating biomechanical cues.

Front. Physiol. 2018; 9: 1417

• Huh D.
• et al.

Reconstituting organ-level lung functions on a chip.

Science. 2010; 328: 1662-1668

• Huh D.
• et al.

A human disease model of drug toxicity–induced pulmonary edema in a lung-on-a-chip microdevice.

Sci. Transl. Med. 2012; 4159ra147

• Ma J.
• et al.

Bioprinting of 3D tissues/organs combined with microfluidics.

RSC Adv. 2018; 8: 21712-21727

• Zhang Y.S.
• Khademhosseini A.

Engineering in vitro human tissue models through bio-design and manufacturing.

Bio-Design Manuf. 2020; 3: 155-159

• Park J.Y.
• et al.

3D Bioprinting and its application to organ-on-a-chip.

Microelectron. Eng. 2018; 200: 1-11

• Klak M.
• et al.

Novel strategies in artificial organ development: what is the future of medicine?.

Micromachines. 2020; 11: 1-29

• Grigoryan B.
• et al.

Multivascular networks and functional intravascular topologies within biocompatible hydrogels.

Science. 2019; 364: 458-464

• Cao X.
• et al.

A tumor-on-a-chip system with bioprinted blood and lymphatic vessel pair.

Adv. Funct. Mater. 2019; 291807173

• Sasmal P.
• et al.

3D bioprinting for modelling vasculature.

Microphysiol. Syst. 2018; 2: 9

• Kolesky D.B.
• et al.

Three-dimensional bioprinting of thick vascularized tissues.

Proc. Natl. Acad. Sci. U. S. A. 2016; 113: 3179-3184

• Li J.
• et al.

Improving bioprinted volumetric tumor microenvironments in vitro.

Trends Cancer. 2020; 6: 745-756

• Gaspar V.M.
• et al.

Advanced bottom-up engineering of living architectures.

Adv. Mater. 2019; 321903975

• Moorman A.M.
• et al.

The prognostic value of tumour-stroma ratio in triple-negative breast cancer.

Eur. J. Surg. Oncol. 2012; 38: 307-313

• Tanaka H.Y.
• et al.

Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements.

Biomaterials. 2020; 251120077

• Zhao K.
• et al.

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.

EBioMedicine. 2020; 61103054

• Millar E.K.A.
• et al.

Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer.

Cancers (Basel). 2020; 12: 3749

• Irmisch A.
• et al.

The tumor profiler study: integrated, multi-omic, functional tumor profiling for clinical decision support.

Cancer Cell. 2021; 39: 288-293

• Zanotelli V.R.T.
• et al.

A quantitative analysis of the interplay of environment, neighborhood, and cell state in 3D spheroids.

Mol. Syst. Biol. 2020; 16e9798

• Hölzl K.
• et al.

Bioink properties before, during and after 3D bioprinting.

Biofabrication. 2016; 8032002

• Gopinathan J.
• Noh I.

Recent trends in bioinks for 3D printing.

22. 2018: 1-15

• Gungor-Ozkerim P.S.
• et al.

Bioinks for 3D bioprinting: an overview.

Biomater. Sci. 2018; 6: 915-946

• Ferreira L.P.
• et al.

Decellularized extracellular matrix for bioengineering physiomimetic 3D in vitro tumor models.

Trends Biotechnol. 2020; 38: 1-18

• Curley C.J.
• et al.

An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure.

Drug Deliv. Transl. Res. 2019; 9: 1-13

• Yin J.
• et al.

3D bioprinting of low-concentration cell-laden gelatin methacrylate (GelMA) bioinks with a two-step cross-linking strategy.

ACS Appl. Mater. Interfaces. 2018; 10: 6849-6857

• Lin C.C.
• Korc M.

Designer hydrogels: shedding light on the physical chemistry of the pancreatic cancer microenvironment.

Cancer Lett. 2018; 436: 22-27

• Ali M.
• et al.

A photo-crosslinkable kidney ECM-derived bioink accelerates renal tissue formation.

Adv. Healthc. Mater. 2019; 8: 1-10

• Skylar-Scott M.A.
• et al.

Voxelated soft matter via multimaterial multinozzle 3D printing.

Nature. 2019; 575: 330-335

• Cameron T.
• et al.

Development of a disposable single-nozzle printhead for 3D bioprinting of continuous multi-material constructs.

Micromachines. 2020; 11: 459

Zhang, Y.S. and Khademhosseini, A. The Brigham and Women’s Hospital. Systems and methods for in vivo multi-material bioprinting, WO201784839A1

• Miri A.K.
• et al.

Bioprinters for organs-on-chips.

Biofabrication. 2019; 11: 42002

• Behroodi E.
• et al.

A combined 3D printing/CNC micro-milling method to fabricate a large-scale microfluidic device with the small size 3D architectures: an application for tumor spheroid production.

Sci. Rep. 2020; 10: 1-14

• Knowlton S.
• et al.

Towards single-step biofabrication of organs on a chip via 3D printing.

Trends Biotechnol. 2016; 34: 685-688

• Datta P.
• et al.

3D bioprinting for reconstituting the cancer microenvironment.

NPJ Precis. Oncol. 2020; 4: 18

• Sun H.
• et al.

Combining additive manufacturing with microfluidics: an emerging method for developing novel organs-on-chips.

Curr. Opin. Chem. Eng. 2020; 28: 1-9

• Lee H.
• Cho D.W.

One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology.

Lab Chip. 2016; 16: 2618-2625

• Park W.
• et al.

3D cell-printed hypoxic cancer-on-a-chip for recapitulating pathologic progression of solid cancer.

J. Vis. Exp. 2021; ()

• Gokaltun A.
• et al.

Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology.

Technology. 2017; 5: 1-12

• Grant J.
• et al.

Simulating drug concentrations in PDMS microfluidic organ chips.

Lab Chip. 2021; ()

• Pourmand A.
• et al.

Fabrication of whole-thermoplastic normally closed microvalve, micro check valve, and micropump.

Sensors Actuators B Chem. 2018; 262: 625-636

• Ali S.
• et al.

Rapid prototyping of whole-thermoplastic microfluidics with built-in microvalves using laser ablation and thermal fusion bonding.

Sensors Actuators B Chem. 2018; 255: 100-109

• Campbell S.B.
• et al.

Beyond polydimethylsiloxane: alternative materials for fabrication of organ-on-a-chip devices and microphysiological systems.

ACS Biomater. Sci. Eng. 2021; 7: 2880-2899

• Nie J.
• et al.

Hydrogels: the next generation body materials for microfluidic chips?.

Small. 2020; 2003797: 1-26

• Li Y.
• et al.

3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of metuzumab.

Biofabrication. 2019; 11: 34102

• Asano Y.
• et al.

Ultrastructure of blood and lymphatic vascular networks in three-dimensional cultured tissues fabricated by extracellular matrix nanofilm-based cell accumulation technique.

Microscopy. 2014; 63: 219-226

• Nishiguchi A.
• et al.

In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis.

Biomaterials. 2018; 179: 144-155

• Liu T.
• et al.

Investigating lymphangiogenesis in a sacrificially bioprinted volumetric model of breast tumor tissue.

Methods. 2021; 190: 72-79

• Yi H.G.
• et al.

A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy.

Nat. Biomed. Eng. 2019; 3: 509-519

• Horowitz L.F.
• et al.

Multiplexed drug testing of tumor slices using a microfluidic platform.

NPJ Precis. Oncol. 2020; 4: 1-15

• Chang T.C.
• et al.

Parallel microfluidic chemosensitivity testing on individual slice cultures.

Lab Chip. 2014; 14: 4540-4551

• Aleman J.
• et al.

Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices.

Nat. Protoc. 2021; 16: 2564-2593

• Maulana T.I.
• et al.

Immunocompetent cancer-on-chip models to assess immuno-oncology therapy.

Adv. Drug Deliv. Rev. 2021; 173: 281-305

• Choi Y.
• et al.

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice.

Exp. Mol. Med. 2018; 50: 1-9

• Barney L.E.
• et al.

The predictive link between matrix and metastasis.

Curr. Opin. Chem. Eng. 2016; 11: 85-93

• Urosevic J.
• Gomis R.R.

Organ-specific metastases.

Nat. Biomed. Eng. 2018; 2: 347-348

• Kühlbach C.
• et al.

A microfluidic system for the investigation of tumor cell extravasation.

Bioengineering. 2018; 5: 1-20

• Van Duinen V.
• et al.

Microfluidic 3D cell culture: from tools to tissue models.

Curr. Opin. Biotechnol. 2015; 35: 118-126

• Surendran V.
• et al.

A novel tumor-immune microenvironment (TIME)-on-chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellalar traps (NETs)-mediated collective tumor invasion.

Biofabrication. 2021; 13035029

• Cui H.
• et al.

Engineering a novel 3D printed vascularized tissue model for investigating breast cancer metastasis to bone.

Adv. Healthc. Mater. 2020; 91900924

• Maharjan S.
• et al.

3D immunocompetent organ-on-a-chip models.

Small Methods. 2020; 42000235

• Wang M.
• et al.

Role of tumor microenvironment in tumorigenesis.

J. Cancer. 2017; 8: 761-773

• Schnittert J.
• et al.

Targeting pancreatic stellate cells in cancer.

Trends Cancer. 2019; 5: 128-142

• Bu L.
• et al.

Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.

Oncogene. 2019; 38: 4887-4901

• Sun Q.
• et al.

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.

Theranostics. 2018; 8: 5072-5087

• Sazeides C.
• Le A.

Metabolic relationship between cancer- ­ associated fibroblasts and cancer cells.

Adv. Exp. Med. Biol. 2018; 1063: 149-165

• Erdogan B.
• Webb D.J.

Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.

Biochem. Soc. Trans. 2017; 45: 229-236

• Torphy R.J.
• et al.

Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.

Mol. Carcinog. 2020; 59: 775-782

• De Jaeghere E.A.
• et al.

Fibroblasts fuel immune escape in the tumor microenvironment.

Trends Cancer. 2019; 5: 704-723

• Xu S.
• et al.

The role of collagen in cancer: from bench to bedside.

J. Transl. Med. 2019; 17: 309

• Pereira B.A.
• et al.

CAF subpopulations: a new reservoir of stromal targets in pancreatic cancer.

Trends Cancer. 2019; 5: 724-741

• Pradhan S.
• et al.

A microvascularized tumor-mimetic platform for assessing anti-cancer drug efficacy.

Sci. Rep. 2018; 8: 1-15

• Ma X.
• et al.

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.

Adv. Drug Deliv. Rev. 2018; 132: 235-251

• Hermida M.A.
• et al.

Three dimensional in vitro models of cancer: bioprinting multilineage glioblastoma models.

Adv. Biol. Regul. 2020; 75100658

• Mao S.
• et al.

Bioprinting of in vitro tumor models for personalized cancer treatment: a review.

Biofabrication. 2020; 12: 42001

• Albrecht I.
• Christofori G.

Molecular mechanisms of lymphangiogenesis in development and cancer.

Int. J. Dev. Biol. 2011; 55: 483-494

• Groll J.
• et al.

Biofabrication: reappraising the definition of an evolving field.

Biofabrication. 2016; 8: 13001

• Mota C.
• et al.

Bioprinting: from tissue and organ development to in vitro models.

Chem. Rev. 2020; 120: 10547-10607

• Heinrich M.A.
• et al.

3D bioprinting: from benches to translational applications.

Small. 2019; 151805510

• Moroni L.
• et al.

Biofabrication strategies for 3D in vitro models and regenerative medicine.

Nat. Rev. Mater. 2018; 3: 21-37

• Kang Y.
• et al.

3D bioprinting of tumor models for cancer research.

ACS Appl. Bio Mater. 2020; 3: 5552-5573

• Sánchez-Salazar M.G.
• et al.

Advances in 3D bioprinting for the biofabrication of tumor models.

Bioprinting. 2021; 21e00120

• Dzobo K.
• et al.

Recent trends in decellularized extracellular matrix bioinks for 3D printing: an updated review.

Int. J. Mol. Sci. 2019; 20: 4628

• Muir V.G.
• Burdick J.A.

Chemically modified biopolymers for the formation of biomedical hydrogels.

Chem. Rev. 2020; ()

• Aldana A.A.
• et al.

Trends in double networks as bioprintable and injectable hydrogel scaffolds for tissue regeneration.

ACS Biomater. Sci. Eng. 2021; ()

• Lee M.
• et al.

Nanocomposite bioink exploits dynamic covalent bonds between nanoparticles and polysaccharides for precision bioprinting.

Biofabrication. 2020; 12: 25025

• Lyu J.
• et al.

Instant gelation system as self-healable and printable 3D cell culture bioink based on dynamic covalent chemistry.

ACS Appl. Mater. Interfaces. 2020; 12: 38918-38924

• McCormack A.
• et al.

3D printing in suspension baths: keeping the promises of bioprinting afloat.

Trends Biotechnol. 2020; 38: 584-593

• Mirdamadi E.
• et al.

FRESH 3D bioprinting a full-size model of the human heart.

ACS Biomater. Sci. Eng. 2020; 6: 6453-6459

• Hinton T.J.
• et al.

Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels.

Sci. Adv. 2015; 1e1500758

• Ayuso J.M.
• et al.

Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model.

Oncoimmunology. 2019; 81553477

• Aref A.R.
• et al.

3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.

Lab Chip. 2018; 18: 3129-3143